These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Marek's disease--the disease and its prevention by vaccination. Biggs PM Br J Cancer Suppl; 1975 Mar; 2():152-5. PubMed ID: 170953 [TBL] [Abstract][Full Text] [Related]
3. Development of a cell line system susceptible to infection with vaccine strains of MDV. Abujoub AA; Williams DL; Reilly JD Acta Virol; 1999; 43(2-3):186-91. PubMed ID: 10696443 [TBL] [Abstract][Full Text] [Related]
4. Marek's disease: a model for protection against herpesvirus-induced tumours. Schat KA Cancer Surv; 1987; 6(1):1-37. PubMed ID: 2825984 [TBL] [Abstract][Full Text] [Related]
5. Partial inhibition by turkey herpesvirus of serotype 2 Marek's disease virus plaque formation and in vivo infectivity. Witter RL; Bacon LD; Calvert JG Avian Dis; 1994; 38(4):800-9. PubMed ID: 7702514 [TBL] [Abstract][Full Text] [Related]
7. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus. Nazerian K; Witter RL; Lee LF; Yanagida N Avian Dis; 1996; 40(2):368-76. PubMed ID: 8790888 [TBL] [Abstract][Full Text] [Related]
8. Influence of Marek's disease virus strain AC-1 on cellular immunity in birds carrying endogenous viral genes. Lessard M; Hutchings DL; Spencer JL; Lillehoj HS; Gavora JS Avian Dis; 1996; 40(3):645-53. PubMed ID: 8883796 [TBL] [Abstract][Full Text] [Related]
9. Marek's disease virus (MDV) antigens in the feather follicle epithelium: difference between oncogenic and nononcogenic MDV. Rangga-Tabbu C; Cho BR Avian Dis; 1982; 26(4):907-17. PubMed ID: 6297453 [TBL] [Abstract][Full Text] [Related]
10. Turkey herpesvirus infection in chickens: induction of lymphoproliferative lesions and characterization of vaccinal immunity against Marek's disease. Witter RL; Sharma JM; Offenbecker L Avian Dis; 1976; 20(4):676-92. PubMed ID: 186008 [TBL] [Abstract][Full Text] [Related]
11. Influence of maternal antibody on efficacy of embryo vaccination with cell-associated and cell-free Marek's disease vaccine. Sharma JM; Graham CK Avian Dis; 1982; 26(4):860-70. PubMed ID: 6297450 [TBL] [Abstract][Full Text] [Related]
12. Prevention of Marek's disease: a review. Purchase HG Cancer Res; 1976 Feb; 36(2 pt 2):696-700. PubMed ID: 766959 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies with specificity for three different serotypes of Marek's disease viruses in chickens. Lee LF; Liu X; Witter RL J Immunol; 1983 Feb; 130(2):1003-6. PubMed ID: 6184394 [TBL] [Abstract][Full Text] [Related]
14. Serological characteristics of a membrane glycoprotein gp82 of Marek's disease virus. Wu P; Lee LF; Reed WM Avian Dis; 1997; 41(4):824-31. PubMed ID: 9454915 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens. Geerligs H; Quanz S; Suurland B; Spijkers IE; Rodenberg J; Davelaar FG; Jongsma B; Kumar M Vaccine; 2008 Oct; 26(44):5595-600. PubMed ID: 18706949 [TBL] [Abstract][Full Text] [Related]
16. Embryo vaccination against Marek's disease with serotypes 1, 2 and 3 vaccines administered singly or in combination. Sharma JM; Witter RL Avian Dis; 1983; 27(2):453-63. PubMed ID: 6307248 [TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence. Shamblin CE; Greene N; Arumugaswami V; Dienglewicz RL; Parcells MS Vet Microbiol; 2004 Sep; 102(3-4):147-67. PubMed ID: 15327791 [TBL] [Abstract][Full Text] [Related]
18. Influence of vaccination with avirulent herpesvirus on subsequent infection of chickens with virulent Marek's disease herpesvirus. Spencer JL; Robertson A Am J Vet Res; 1975 Aug; 36(08):1235-9. PubMed ID: 168799 [TBL] [Abstract][Full Text] [Related]
19. Marek's disease and new approaches to its control. ZelnÃk V Acta Virol; 1995 Feb; 39(1):53-63. PubMed ID: 7572471 [TBL] [Abstract][Full Text] [Related]
20. Study of host-pathogen interactions to identify sustainable vaccine strategies to Marek's disease. Baaten BJ; Butter C; Davison TF Vet Immunol Immunopathol; 2004 Aug; 100(3-4):165-77. PubMed ID: 15207454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]